Search for: "Hyman Phelps McNamara"
Results 181 - 200
of 214
Sorted by Relevance
|
Sort by Date
6 Feb 2024, 7:39 pm
Karst —The House Committee on Energy and Commerce Subcommittee on Oversight and Investigations invited Hyman, Phelps & McNamara, P.C. [read post]
12 Aug 2010, 2:28 am
Karst, Hyman, Phelps & McNamara, P.C., United States Klaus Kupka, Taylor Wessing, Germany David C. [read post]
25 Oct 2015, 8:03 pm
., Director, Hyman, Phelps & McNamara, P.C. [read post]
6 Dec 2023, 9:36 pm
Javitt —On Monday, Hyman, Phelps & McNamara, P.C. filed comments on behalf of the Coalition to Preserve LDT Access and Innovation in response to FDA’s proposed rule to regulate laboratory developed tests (LDTs) as devices. [read post]
30 Jun 2010, 10:15 am
NORD Board of Directors Chairman (and Hyman, Phelps & McNamara, P.C. [read post]
21 Dec 2023, 7:36 pm
While “The Singing Cowboy” Gene Autry was busy in Los Angeles recording Rudolph the Red-Nosed Reindeer, The Food and Drug Law Institute (FDLI) founders were hard at work in Washington forming the association that still serves as the platform for discussing complex legal and regulatory issues associated with food, drugs, cosmetics, medical devices, and other health-related products. 2024 brings a host of Hyman, Phelps & McNamara, P.C. [read post]
22 Dec 2022, 12:44 am
(Hyman, Phelps & McNamara, P.C., was co-counsel for the Judge Rotenberg Center in this litigation.) [read post]
30 Nov 2010, 8:35 am
He’s a newcomer to the blogosphere and well worth the read; Drug & Device Law: BigLaw firm Dechert has a group blog that focuses on the defense of, well, drug and device cases; FDA Law Blog: Another newcomer to the blogosphere, the firm of Hyman, Phelps & McNamara focuses on government regulation of the food and drug biz; Jackson on Consumer Class Action and Mass Torts: Another BigLaw entry, this by Russell Jackson at Skadden, Arps, Slate, Meagher &… [read post]
16 Jul 2010, 9:39 am
The NORD Board of Directors is chaired by Hyman, Phelps & McNamara, P.C. [read post]
28 Apr 2007, 10:55 am
A recent entry in that area is the FDA Law Blog, hosted by some lawyers at Hyman Phelps & McNamara. [read post]
26 Mar 2024, 2:53 am
Hyman, Phelps & McNamara, P.C. [read post]
3 May 2011, 7:16 am
Mylan was represented by Douglas Farquhar of Washington’s Hyman, Phelps & McNamara, who declined to comment when reached Monday evening. [read post]
12 Aug 2013, 9:30 pm
Michelle Butler, a lawyer with Hyman, Phelps & McNamara who filed a whitepaper with the FDA, argues that the bar for demonstrating clinical superiority is too high. [read post]
6 Nov 2007, 9:57 pm
Anonymous tentatively approved filer (with support from Sandoz and Apotex) The law firm of Hyman, Phelps & McNamara ("HPM") submitted a letter "on behalf of a company with a tentatively approved ANDA" for ramipril. [read post]
11 Oct 2011, 1:53 pm
Chairman of the NORD Board of Directors and Hyman, Phelps & McNamara, P.C. [read post]
25 Apr 2012, 9:05 am
Hyman, Phelps & McNamara P.C. represents Akorn in this matter. [read post]
29 Sep 2022, 5:56 pm
Hyman, Phelps & McNamara, P.C. [read post]
14 Oct 2012, 6:04 pm
Ricardo Carvajal, of Hyman, Phelps & McNamara, points out that the Department of Justice, for the FDA, requested rehearing and rehearing en banc in R.J. [read post]
3 Aug 2022, 2:21 am
Gibbs, Hyman, Phelps & McNamara, Docket No. 92P-0405 (Aug. 12, 1998) (available here). [read post]
11 Mar 2024, 7:32 pm
FDA has gone so far as to rescinded at least one 510(k) based on its determination that allegedly unreliable data have been submitted, even in the case where discrepancies in the data were obvious and not caught during FDA’s own review of the submission and subsequently explained as a simple mistake (Stay of Action Petition from Hyman, Phelps & McNamara, P.C. [read post]
